Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Titlesort descending Journal
Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials Expert Review of Gastroenterology and Hepatology
Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials The Breast
Incidence and predictors of 1-year mortality among 9236 breast cancer patients referred for adjuvant chemotherapy Future Oncology
Incumbent Firm Capacity Building in Analytics: Strategy, Structure, and Innovation Management Perspectives IEEE Journal of Biomedical and Health Informatics
Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies Dovepress
Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes European Urology
Integrated but Isolated: Implications from a Systematic Review of the Access Control Ecosystem for Individual Participant Data in Clinical Studies John Wiley & Sons, Ltd (asis&t)
KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials Database
Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer The Oncologist
Learning Conditional Variational Autoencoders with Missing Covariates arXiv
Leveraging external data in the design and analysis of clinical trials in neuro-oncology Lancet Oncology
Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer Algorithms
Matrix decomposition in meta‐analysis for extraction of adverse event pattern and patient‐level safety profile Pharmaceutical Statistics
Merck KGaA, Darmstadt, Germany, Recognized for Collaborative Cancer Research by CEO Roundtable on Cancer PR Newswire

Pages